1,3-dipropyl-8-cyclopentylxanthine has been researched along with Idiopathic Parkinson Disease in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The adenosine inhibition was abolished by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective adenosine A1 receptor antagonist." | 1.31 | Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. ( Aceves, J; Barajas, C; Erlij, D; Florán, B; Florán, L, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mango, D | 1 |
| Bonito-Oliva, A | 1 |
| Ledonne, A | 1 |
| Cappellacci, L | 1 |
| Petrelli, R | 1 |
| Nisticò, R | 1 |
| Berretta, N | 1 |
| Fisone, G | 1 |
| Mercuri, NB | 1 |
| Florán, B | 1 |
| Barajas, C | 1 |
| Florán, L | 1 |
| Erlij, D | 1 |
| Aceves, J | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
Topics: Action Potentials; Age Factors; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Anim | 2014 |
Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Animals; Calcium Signaling; Dopamine Agonists; Do | 2002 |